Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics

ASRT POWR Grades

• Value is the dimension where ASRT ranks best; there it ranks ahead of 99.45% of US stocks.
• ASRT's strongest trending metric is Growth; it's been moving down over the last 177 days.
• ASRT's current lowest rank is in the Stability metric (where it is better than 7.86% of US stocks).

ASRT Stock Summary

• With a price/earnings ratio of 4.1, ASSERTIO HOLDINGS INC P/E ratio is greater than that of about just 9.63% of stocks in our set with positive earnings.
• The price/operating cash flow metric for ASSERTIO HOLDINGS INC is higher than merely 8.7% of stocks in our set with a positive cash flow.
• Over the past twelve months, ASRT has reported earnings growth of -184.5%, putting it ahead of just 8.65% of US stocks in our set.
• Stocks that are quantitatively similar to ASRT, based on their financial statements, market capitalization, and price volatility, are STKS, DXC, RUTH, SHEN, and NNBR.
• ASRT's SEC filings can be seen here. And to visit ASSERTIO HOLDINGS INC's official web site, go to www.assertiotx.com.

ASRT Valuation Summary

• ASRT's price/sales ratio is 0.8; this is 82.8% lower than that of the median Healthcare stock.
• ASRT's price/earnings ratio has moved up 5.9 over the prior 243 months.

Below are key valuation metrics over time for ASRT.

ASRT Growth Metrics

Its 5 year cash and equivalents growth rate is now at 17.28%.
• Its 5 year price growth rate is now at -96.2%.
• Its 5 year revenue growth rate is now at -56.56%.

Over the past 15 months, ASRT's revenue has gone up $18,272,000.

The table below shows ASRT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	130.469	50.641	25.241
2022-03-31	120.711	37.175	3.238
2021-12-31	111.014	5.523	-1.281
2021-09-30	107.86	-4.59	-30.241
2021-06-30	116.953	-23.675	-44.5
2021-03-31	112.197	-44.735	-64.83

ASRT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ASRT has a Quality Grade of C, ranking ahead of 35.61% of graded US stocks.
• ASRT's asset turnover comes in at 0.367 -- ranking 129th of 680 Pharmaceutical Products stocks.
• NOVN, ARWR, and RIOT are the stocks whose asset turnover ratios are most correlated with ASRT.

The table below shows ASRT's key quality metrics over time.